FR2228477A1 - - Google Patents

Info

Publication number
FR2228477A1
FR2228477A1 FR7415780A FR7415780A FR2228477A1 FR 2228477 A1 FR2228477 A1 FR 2228477A1 FR 7415780 A FR7415780 A FR 7415780A FR 7415780 A FR7415780 A FR 7415780A FR 2228477 A1 FR2228477 A1 FR 2228477A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7415780A
Other languages
French (fr)
Other versions
FR2228477B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohio State University
Original Assignee
Ohio State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohio State University filed Critical Ohio State University
Publication of FR2228477A1 publication Critical patent/FR2228477A1/fr
Application granted granted Critical
Publication of FR2228477B1 publication Critical patent/FR2228477B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/5555—Muramyl dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7415780A 1973-05-07 1974-05-07 Expired FR2228477B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35789273A 1973-05-07 1973-05-07
US40682173A 1973-10-16 1973-10-16

Publications (2)

Publication Number Publication Date
FR2228477A1 true FR2228477A1 (en) 1974-12-06
FR2228477B1 FR2228477B1 (en) 1977-07-01

Family

ID=26999834

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7415780A Expired FR2228477B1 (en) 1973-05-07 1974-05-07

Country Status (17)

Country Link
JP (1) JPS623128B2 (en)
AT (1) AT356263B (en)
AU (1) AU524925B2 (en)
CA (1) CA1057742A (en)
CH (1) CH622426A5 (en)
DD (1) DD113919A5 (en)
DE (1) DE2421943A1 (en)
FR (1) FR2228477B1 (en)
GB (1) GB1473601A (en)
HK (1) HK41280A (en)
IE (1) IE42002B1 (en)
IL (1) IL44779A (en)
MY (1) MY8100128A (en)
NL (1) NL7406098A (en)
NZ (1) NZ174192A (en)
PL (1) PL97318B1 (en)
SE (1) SE7406096L (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2319379A1 (en) * 1975-07-29 1977-02-25 All India Inst Medical Scie Contraceptive vaccine for women - comprising a conjugate of tetanus anatoxin andhuman chlorionic gonadotrophin (3-sub-unit with no strong reaction with anti-LH serium)
FR2383919A1 (en) * 1977-03-14 1978-10-13 Hoffmann La Roche DETERMINATION OF B-ENDORPHINE
FR2832066A1 (en) * 2001-11-14 2003-05-16 Agronomique Inst Nat Rech CONTRACEPTIVE VACCINE COMPOSITIONS COMPRISING A PEPTIDE OR A SET OF PEPTIDES ENCODED BY ALL OR PART OF EXON 1 OF AN FSH RECEPTOR

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526716A (en) * 1981-11-20 1985-07-02 The Ohio State University Antigenic modification of polypeptides
CA1054937A (en) * 1975-01-28 1979-05-22 Gursaran P. Talwar Antipregnancy vaccine
JPS55160725A (en) * 1975-07-30 1980-12-13 Paashiyado Taruwaa Gaasaran Contraceptive vaccine and its manufacture
NZ182272A (en) * 1975-10-14 1985-03-20 Univ Ohio State Modified polypeptides for the immunological control of fertility,and pharmaceutical compositions
JPS5294416A (en) * 1976-01-24 1977-08-09 Paashiyado Taruwaa Gaasaran Vaccine for contraception and use of same
JPS5633907Y2 (en) * 1976-09-16 1981-08-11
US4234561A (en) * 1978-02-06 1980-11-18 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
US4310455A (en) * 1979-04-17 1982-01-12 Research Corporation Antigen for early pregnancy test and contraceptive vaccine
CA1239346A (en) * 1985-06-04 1988-07-19 Gursaran P. Talwar Birth control vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA903671A (en) * 1972-06-27 J. Lewis Andrew Soluble cancer antigens coupled to foreign proteins
DE1467782A1 (en) * 1963-07-17 1968-12-12 Behringwerke Ag Process for the production of artificial antigens
US3317400A (en) * 1964-11-23 1967-05-02 Upjohn Co Enzymatic modification of bovine growth hormone by proteolytic streptomycete cell extracts
GB1393965A (en) * 1971-05-05 1975-05-14 Ortho Pharma Corp Vaccine and method for inducing infertility in a male animal

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2319379A1 (en) * 1975-07-29 1977-02-25 All India Inst Medical Scie Contraceptive vaccine for women - comprising a conjugate of tetanus anatoxin andhuman chlorionic gonadotrophin (3-sub-unit with no strong reaction with anti-LH serium)
FR2383919A1 (en) * 1977-03-14 1978-10-13 Hoffmann La Roche DETERMINATION OF B-ENDORPHINE
FR2832066A1 (en) * 2001-11-14 2003-05-16 Agronomique Inst Nat Rech CONTRACEPTIVE VACCINE COMPOSITIONS COMPRISING A PEPTIDE OR A SET OF PEPTIDES ENCODED BY ALL OR PART OF EXON 1 OF AN FSH RECEPTOR
WO2003041732A2 (en) * 2001-11-14 2003-05-22 Institut National De La Recherche Agronomique-Inra Contraceptive vaccine compositions comprising a peptide or a plurality of peptides encoded by all or part of the exon 1 of a fsh receptor
WO2003041732A3 (en) * 2001-11-14 2004-01-22 Agronomique Inst Nat Rech Contraceptive vaccine compositions comprising a peptide or a plurality of peptides encoded by all or part of the exon 1 of a fsh receptor

Also Published As

Publication number Publication date
SE7406096L (en) 1975-01-31
NL7406098A (en) 1974-11-11
IL44779A0 (en) 1974-07-31
AU524925B2 (en) 1982-10-14
MY8100128A (en) 1981-12-31
JPS5069221A (en) 1975-06-10
AT356263B (en) 1980-04-25
CA1057742A (en) 1979-07-03
HK41280A (en) 1980-08-15
IE42002L (en) 1974-11-07
FR2228477B1 (en) 1977-07-01
NZ174192A (en) 1985-02-28
JPS623128B2 (en) 1987-01-23
DD113919A5 (en) 1975-07-05
AU6869574A (en) 1975-11-13
IE42002B1 (en) 1980-05-21
PL97318B1 (en) 1978-02-28
IL44779A (en) 1977-10-31
CH622426A5 (en) 1981-04-15
DE2421943C2 (en) 1989-10-26
ATA377074A (en) 1979-09-15
DE2421943A1 (en) 1974-11-28
GB1473601A (en) 1977-05-18

Similar Documents

Publication Publication Date Title
AU476761B2 (en)
AR201235Q (en)
AR201231Q (en)
AU450229B2 (en)
AU476714B2 (en)
FR2228477B1 (en)
AR201229Q (en)
AR199451A1 (en)
AU477823B2 (en)
AR196382A1 (en)
AU476873B1 (en)
AU477824B2 (en)
AR197627A1 (en)
AR200256A1 (en)
AR200885A1 (en)
AR201432A1 (en)
CH559447A5 (en)
CH562517A5 (en)
CH562047A5 (en)
CH560732A5 (en)
AU479419A (en)
AU479404A (en)
CH1722673A4 (en)
BG25943A1 (en)
BG18937A1 (en)

Legal Events

Date Code Title Description
ST Notification of lapse